POST-MARKETING SAFETY STUDIES Authors' reply to Fralick and Kesselheim

被引：0
|
作者：
Spelsberg, Angela [1 ,2 ]
Keil, Ulrich [3 ]
Prugger, Christof [4 ]
机构：
[1] Transparency Int Germany, Working Grp Hlth, Pauwelsstr 30, D-52074 Aachen, Germany
[2] Comprehens Canc Ctr Aachen, Pauwelsstr 30, D-52074 Aachen, Germany
[3] Univ Munster, Inst Epidemiol & Social Med, Albert Schweitzer Campus 1, D-48149 Munster, Germany
[4] Charite, Inst Publ Hlth, Seestr 73, D-13347 Berlin, Germany
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2017年 / 357卷
关键词：
D O I：
10.1136/bmj.j1850
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Characteristics of post-marketing studies and their contribution to post-marketing safety measures in Japan
    Kanmuri K.
    Narukawa M.
    Pharmaceutical Medicine, 2014, 28 (2) : 67 - 73
  • [2] POST-MARKETING SAFETY STUDIES Three design aspects for high quality post-marketing cohort studies
    Fralick, Michael
    Kesselheim, Aaron S.
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
  • [3] Post-marketing studies - The work of the Drug Safety Research Unit
    Mackay, FJ
    DRUG SAFETY, 1998, 19 (05) : 343 - 353
  • [4] PREDICTION OF POST-MARKETING SAFETY FROM CLINICAL-STUDIES
    EAST, MO
    RISK AND CONSENT TO RISK IN MEDICINE, 1989, : 39 - 52
  • [5] Efficacy and safety of nateglinide in post-marketing surveillance studies in Japan
    Damholt, BB
    Golor, G
    Wierich, W
    Pedersen, PC
    Ekblom, M
    Zdravkovic, M
    DIABETES, 2005, 54 : A114 - A114
  • [6] Editorial: Pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies
    Khan, Zakir
    Karatas, Yusuf
    Akici, Ahmet
    Martins, Maria Auxiliadora Parreiras
    Ahmad, Nafees
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [7] FDA post-marketing safety decisions
    Klein, Donald F.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (08) : 1305 - 1306
  • [8] Post-marketing device safety surveillance
    Vidi, Venkatesan D.
    Matheny, Michael E.
    Resnic, Frederic S.
    CONTEMPORARY CLINICAL TRIALS, 2011, 32 (03) : 307 - 308
  • [9] Sample size for post-marketing safety studies based on historical controls
    Wu, Yu-te
    Makuch, Robert W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 (08) : 869 - 875
  • [10] AUTHORS'REPLY To the Letter to the Editor by Liu and Kesselheim
    Doherty, Bridget
    Martin, Silas
    Benedict, Agnes
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (07):
12345